Tiger Women Finish 10th At NCAA Cross Country Championship; Cherop, Jelelgo All-Americans

The Clemson women's cross country team finished 10th at the 2026 NCAA National Championship in Terre Haute — the program's first top-10 finish in 36 years — with Nancy Cherop and Silvia Jelelgo earning All-American status.
November 21, 2026
147 Views
Discuss
Story Poster
Photo by ClemsonTigers.com

TERRE HAUTE, IND. – The Clemson women's cross country team competed at the 2026 NCAA National Championship on Saturday, November 21st in their first appearance since 1993. The women finished in 10th overall in the 6K, compiling 326 points.

This outing was the sixth-best NCAA Championship finish in program history, the seventh top-10 finish in program history, and their first top-10 finish in 36 years, since 1990.

Nancy Cherop finished twenty-fourth overall in the 6K, running a time of 19:13.80. Silvia Jelelgo (19:21.80) followed closely behind, finishing in 30th with 25 points. The duo earned All-American status by finishing within the Top-40 at the NCAA Championship.

Women's Full 6K Results | 10th Overall | 326 Points

  • Cherop, 19:13.80 (24th place, 20 points) - All-American
  • Jelelgo, 19:21.80 (30th place, 25 points) - All-American
  • Kosgei, 19:33.70 (52nd place, 42 points)
  • Gladys Chepngeitich, 19:45.70 (66th place, 53 points)
  • Elizabeth Ilanda, 21:11.30 (222nd place, 186 points)
  • Madison Timms, 21:14.80 (230th place, 193 points)
100% Independent. 110% Clemson.
Most of Clemson Sports Talk is available to everyone. CST+ members help make that possible. Support independent Clemson coverage by joining CST+.
🐅 Just $63.17 for one year — Clemson fans know why.
JOIN CST+ — 3 MONTHS FOR $1
Discuss
Discussion from...

Tiger Women Finish 10th At NCAA Cross Country Championship; Cherop, Jelelgo All-Americans

127 Views | 0 Replies | Last: 1 hr ago by CU Athletic Communications
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.